Targeting the Ubiquitin–Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung CancerTAK-243 is a Potential Treatment for Small-Cell Lung Cancer

Overview of attention for article published in Clinical Cancer Research, February 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

blogs: 1 blog

twitter: 17 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 10 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

TAK-243, a Ubiquitin–Proteasome System Inhibitor

Physician's Weekly, 20 Jun 2022

For a study, researchers sought to understand that cisplatin/etoposide chemotherapy (C/E) plus and minus radiotherapy has been…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.